Clinical Analysis of Frostbite

동상의 임상적 분석

  • Choi, Jang Kyu (Department of Surgery, The Armed Forces Capital Hospital) ;
  • Kim, Hyun Chul (Department of Surgery, The Armed Forces Capital Hospital) ;
  • Shin, Hong Kyung (Department of Surgery, The Armed Forces Capital Hospital)
  • Received : 2015.08.21
  • Accepted : 2015.10.04
  • Published : 2015.09.30

Abstract

Purpose: Frostbite can affect still soldiers. Initial clinical manifestations are similar for superficial and deep frostbite, so early treatment is identical. It is under-estimated by physicians. We try to identify the challenges of managing these complex tissue injuries. Methods: A retrospective analysis of 84 patients hospitalized at AFCH from 2009 to 2015 was conducted. We investigated differences of epidemiological characteristics, identification of soft tissue injury, treatment and complications between superficial (SF: 43; 51.2%) and deep (DF: 41; 48.8%) frostbite. Results: The major (94.0%) developed frostbite in dry circumstances (89.3%). Wet circumstances (66.7%) were more susceptible to DF rather than dry (46.7%). The 38 (45.2%) arrived to specialist within 7days. Most prone sites were feet, followed by hands. Toes had more deep injuries. DF presented more increased levels of ALT, CPK, CKMB, CRP. The bone scan of W+S+ was 48.3%, 87.1% and W+S- was 20.7%, 12.9%, respectively. The treatment resulted in improved or normalized perfusion scan with matching clinical improvement. It was a good tool to assess treatment response. Eighteen normal and 8 stenotic type of PCR resulted in normal with matching clinical improvement. One continuous obstructive waveform led to minor amputation. Twelve underwent both PCR and MRA. Among 6 normal PCR, 5 showed normal and one stenosis in MRA. All 5 stenosis and one obstruction showed the same findings in MRA. It was a good tool to evaluate vascular compromise. They were treated with rapid rewarming (11.6%, 22.0%), hydrotherapy (16.3%, 29.3%), respectively. Six (14.6%) underwent STSG, 2 (4.9%) had digital amputation in DF. Berasil, Ibuprofen, Trental were commonly administered. PGE1 was administered selectively for 6.8, 10.8 days, respectively. Raynaud's syndrome (16.3%), CRPS (4.7%), LOM (14.6%) and toe deformity (4.9%) were specific sequelae. Conclusion: We should recommend intensive foot care education, early rewarming and evacuation to specialized units. The bone scanning and PCR should allow for a more aggressive and active approach to the management of tissue viability.

Keywords

References

  1. Imray C, Grieve A, Dhillon S. Cold damage to the extremities: frostbite and non-freezing cold injuries. Postgrad Med J 2009; 85: 481-8. https://doi.org/10.1136/pgmj.2008.068635
  2. McIntosh SE, Opacic M, Freer L, Grissom CK, Auerbach PS, Rodway GW et al. Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite: 2014 update. Wilderness Environ Med 2014; 25(4 Suppl): S43-54. https://doi.org/10.1016/j.wem.2014.09.001
  3. Shin HK, Kim HC, Hong IK. Analysis of Frostbite(1). J Korean Burn Soc 2011; 14: 128-42.
  4. Cauchy E, Chetaille E, Lefevre M, Kerelou E, Marsigny B. The role of bone scanning in severe frostbite of the extremities: a retrospective study of 88 cases. Eur J Nucl Med 2000; 27: 497-502. https://doi.org/10.1007/s002590050534
  5. Bhatnagar A, Sarker BB, Sawroop K, Chopra MK, Sinha N, Kashyap R. Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study. Eur J Nucl Med Mol Imaging 2002; 29: 170-5. https://doi.org/10.1007/s00259-001-0658-4
  6. Barker JR, Haws MJ, Brown RE, Kucan JO, Moore WD. Magnetic resonance imaging of severe frostbite injuries. Ann Plast Surg 1997; 38: 275-9. https://doi.org/10.1097/00000637-199703000-00015
  7. Smith DJ, Bendick PJ, Madison SA. Evaluation of vascular compromise in the injured extremity: a photoplethysmographic technique. J Hand Surg Am 1984; 9: 314-9. https://doi.org/10.1016/S0363-5023(84)80215-4
  8. Britt LD, Dascombe WH, Rodriguez A. New horizons in management of hypothermia and frostbite injury. Surg Clin North Am 1991; 71: 345-70. https://doi.org/10.1016/S0039-6109(16)45384-3
  9. Mills WJ. Frostbite. A method of management including rapid thawing. Northwest Med 1966; 65: 119-25.
  10. Murphy JV, Banwell PE, Roberts AH, McGrouther DA. Frostbite: pathogenesis and treatment. J Trauma 2000; 48: 171-8. https://doi.org/10.1097/00005373-200001000-00036
  11. McCauley RL, Hing DN, Robson MC, Heggers JP. Frostbite injuries: a rational approach based on the pathophysiology. J Trauma 1983; 23: 143-7. https://doi.org/10.1097/00005373-198302000-00013
  12. Zafren K. Frostbite: prevention and initial management. High Alt Med Biol 2013; 14: 9-12. https://doi.org/10.1089/ham.2012.1114
  13. Jurkovich GJ. Environmental cold-induced injury. Surg Clin North Am 2007; 87: 247-67. https://doi.org/10.1016/j.suc.2006.10.003
  14. Erikson U, Ponten B. The possible value of arteriography supplemented by a vasodilator agent in the early assessment of tissue viability in frostbite. Injury 1974; 6: 150-3. https://doi.org/10.1016/0020-1383(74)90008-4
  15. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 2009; 17: 275-342. https://doi.org/10.1007/s10787-009-0016-x
  16. Mills WJ. Comments on this issue of Alaska Medicine--from then (1960) until now (1993). Alaska Med 1993; 35: 70-87.
  17. Yeager RA, Campion TW, Kerr JC, Hobson RW, Lynch TG. Treatment of frostbite with intra-arterial prostaglandin E1. Am Surg 1983; 49: 665-7.
  18. Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med 2011; 364: 189-90. https://doi.org/10.1056/NEJMc1000538
  19. Daum PS, Bowers WD, Tejada J, Morehouse D, Hamlet MP. An evaluation of the ability of the peripheral vasodilator buflomedil to improve vascular patency after acute frostbite. Cryobiology 1989; 26: 85-92. https://doi.org/10.1016/0011-2240(89)90036-9
  20. Bouwman DL, Morrison S, Lucas CE, Ledgerwood AM. Early sympathetic blockade for frostbite--is it of value? J Trauma 1980; 20: 744-9. https://doi.org/10.1097/00005373-198009000-00006
  21. Hayes DW, Mandracchia VJ, Considine C, Webb GE. Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite. Clin Podiatr Med Surg 2000; 17: 715-22.
  22. Bruen KJ, Ballard JR, Morris SE, Cochran A, Edelman LS, Saffle JR. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg 2007; 142: 546-51. https://doi.org/10.1001/archsurg.142.6.546
  23. Johnson AR, Jensen HL, Peltier G, DelaCruz E. Efficacy of intravenous tissue plasminogen activator in frostbite patients and presentation of a treatment protocol for frostbite patients. Foot Ankle Spec 2011; 4: 344-8. https://doi.org/10.1177/1938640011422596
  24. Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite.